Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis

被引:1
|
作者
Liu, Jing [1 ]
Chen, Wei [1 ]
Shao, Shihuan [1 ]
Chen, Yuanyuan [1 ]
Wang, Hongyi [1 ]
Xi, Yang [1 ]
Wang, Luyan [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Hypertens, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
Angiotensin II AT1 receptor antagonists (ARBs); nocturnal blood pressure; hypertension; meta-analysis; MODERATE ESSENTIAL-HYPERTENSION; SERUM URIC-ACID; DOUBLE-BLIND; ANTIHYPERTENSIVE EFFICACY; CANDESARTAN CILEXETIL; OLMESARTAN MEDOXOMIL; KOREAN PATIENTS; OPEN-LABEL; 50; MG; LOSARTAN;
D O I
10.1080/07853890.2024.2362880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNocturnal blood pressure (BP) is correlated with an increased risk of cardiovascular events and is an important predictor of cardiovascular death in hypertensive patients.ObjectiveNocturnal BP control is of great importance for cardiovascular risk reduction. This systematic review and meta-analysis aimed to explore the efficacy of angiotensin receptor blockers (ARBs) for nocturnal BP reduction in patients with mild to moderate hypertension.MethodsPICOS design structure was used to formulate the data extraction. All statistical calculations and analyses were performed with R.ResultsSeventy-seven studies with 13,314 participants were included. The overall analysis indicated that nocturnal BP drop varied considerably among different ARBs. Allisartan (13.04 [95% CI (-18.41, -7.68)] mmHg), olmesartan (11.67 [95% CI (-14.12, -9.21)] mmHg), telmisartan (11.11 [95% CI (-12.12, -10.11)] mmHg) were associated with greater reduction in nocturnal systolic BP. In the aspect of the nocturnal-diurnal BP drop ratio, only allisartan was greater than 1. While, the variation tendency of last 4-6 h ambulatory BP was basically consistent with nocturnal BP. Additionally, allisartan showed improvement effect in the proportion of patients with dipping BP pattern.ConclusionsThis study demonstrates that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs, while allisartan can reduce nighttime BP more than daytime BP and improve the dipping pattern. This meta-analysis explores the efficacy of Angiotensin II AT1 receptor antagonists (ARBs) on nocturnal blood pressure (BP) reduction in mild to moderate hypertension.The results demonstrate that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs.Allisartan can reduce nighttime BP more effectively than daytime BP, which also improve the dipping pattern.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Different Efficacy of Angiotensin Receptor Blockers for Nocturnal Blood Pressure Reduction in Patients With Mild to Moderate Hypertension: A Systematic Review and Meta-Analysis
    Liu, Jing
    Chen, Wei
    Shao, Shihuan
    Chen, Yuanyuan
    Wang, Hongyi
    Xi, Yang
    Wang, Luyan
    CIRCULATION, 2023, 148
  • [2] Effect of Azilsartan on clinical blood pressure reduction compared to other angiotensin receptor blockers: a systematic review and meta-analysis
    Khan, Qaisar Ali
    Sharma, Shalini
    ul Mulk, Ittehad
    Li, David
    Belay, Naod F.
    Afzal, Muhammad
    Farrukh, Ameer Mustafa
    Asad, Muhammad
    Baqi, Abdul
    Semakieh, Bader
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 958 - 967
  • [3] Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis
    Makani, Harikrishna
    Bangalore, Sripal
    Supariwala, Azhar
    Romero, Jorge
    Argulian, Edgar
    Messerli, Franz H.
    EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1732 - +
  • [4] Efficacy and Safety of Sacubitril Valsartan in Managing Hypertension Compared with Angiotensin Receptor Blockers: A Systematic Review and Meta-analysis
    Sukmadja, Daniel
    Prawara, Ananta Siddhi
    Prasiddha, Kaka Citta
    Tarigan, Tinanda
    JOURNAL OF HYPERTENSION, 2023, 41 (SUPPL 2)
  • [5] A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension
    Chrisa Dimou
    Christina Antza
    Evangelos Akrivos
    Ioannis Doundoulakis
    Stella Stabouli
    Anna Bettina Haidich
    Vasilios Kotsis
    Journal of Human Hypertension, 2019, 33 : 188 - 201
  • [6] A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension
    Dimou, Chrisa
    Antza, Christina
    Akrivos, Evangelos
    Doundoulakis, Ioannis
    Stabouli, Stella
    Haidich, Anna Bettina
    Kotsis, Vasilios
    JOURNAL OF HUMAN HYPERTENSION, 2019, 33 (03) : 188 - 201
  • [7] Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis
    Du, Yuan-Hong
    Guan, Cheng-Jing
    Li, Lin-Yu
    Gan, Ping
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (03) : 1093 - 1101
  • [8] Angiotensin receptor blockers are equally effective in women and men; a systematic review and meta-analysis
    Laven, S.
    Mohseni-Alsalhi, Z.
    Meijs, D.
    Vaes, E.
    Wilmes, N.
    Van Luik, E.
    Vesseur, M.
    De Haas, S.
    Spaanderman, M.
    Ghossein-Doha, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2198 - 2198
  • [9] COMPARATIVE EFFICACY OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS II IN ESSENTIAL HYPERTENSION: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Antza, C.
    Dimou, C.
    Akrivos, E.
    Doundoulakis, I.
    Stabouli, S.
    Haidich, A. B.
    Kotsis, V.
    JOURNAL OF HYPERTENSION, 2018, 36 : E124 - E124
  • [10] Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis
    Batty, Jonathan A.
    Tang, Mengyao
    Hall, Marlous
    Ferrari, Roberto
    Strauss, Martin H.
    Hall, Alistair S.
    SYSTEMATIC REVIEWS, 2018, 7